The cannabis industry has remained one of the markets with the largest amount of potential in recent times. As we move toward the future, it seems as though the combination of positive legislation and the changing public opinion on the substance has all continued to contribute the market’s growth. Many stocks have been able to move to the forefront of the market because of this, and they have remained for the most part, wildly successful.
One of the most popular cannabis companies in the industry and one that should be a household name by now has remained Aphria (APHQF). Aphria has been considered to be one of the largest growers of cannabis throughout Canada and has worked to build their market domestically. Because of their growing ability and their location, Aphria has been said to have an extreme amount of exposure to one of the fastest growing markets on the planet. The company has mainly been focused on the field of medicinal cannabis but has recently been working to get into the market on capsules and vaporizers as well. The company has also stated that they have an interest in getting into the recreational space as well, which could continue to up their exposure as we move toward the coming years. According to one report, analysts “predict profits will grow by 450% to 55-Canadian-cents-per-share (42 cents, USD). That would take the forward P/E for the next fiscal year to around 30.” Aphria remains one the most important stocks to keep an eye on in the market.
The company CannTrust Holdings (CNTTF) has been another one of the primary players in the cannabis space for some time now. Historically, CannTrust has focused upon the medicinal market as well, but the company in recent times has been working to explore the recreational space as well. According to one report “its current P/E ratio currently stands at about 58, coming in even lower than Aphria. Also, investors might find the P/E of 58 worthwhile due to forecasted profit growth. Analysts expect earnings to grow by 236.4% next year.” The company remains one of the more exciting companies to watch as Canada moves forward with the sales of legal recreational cannabis.
Organigram Holdings Inc. (OGRMF) is another company that has traditionally been a large player in the medicinal pot field, but they differ as they have aimed at creating specific strains to treat various illnesses. According to one report “Analysts predict the company will lose 1-Canadian-cent-per-share (0.76 cents, USD) this year. Better yet, expected revenue and sales growth should take OGRMF stock to profitability next year. If these forecasts hold, the company will earn 14-Canadian-cents-per-share (11 cents, USD) next year. This would take the forward P/E on next year’s earnings to 48.” The company has proven to be quite an interesting stock to watch as we move through the future, but with a market cap not as large as the biggest players in the field, it looks like they could have some room to grow in the near future.
The cannabis market has remained incredibly interesting to watch and take part in for some time now, and as legalization efforts continue to see massive amounts of success, it continues to be promising to watch cannabis as a market.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
